<p>Evkeeza is a medicine used together with low-fat diet and other medicines to reduce levels of cholesterol in the blood. It is used in adults, adolescents and children aged 6 months and older with homozygous familial hypercholesterolaemia. This is an inherited disease that increases the levels of low-density lipoprotein <a>cholesterol </a>(LDL cholesterol or ‘bad cholesterol’) in the blood, which is a known risk factor for cardiovascular disease.</p><p>Evkeeza contains the active substance evinacumab.</p>
Therapeutic Indication
<div class="subsection mt-3-5"> <h3>Therapeutic indication</h3><p>Evkeeza is indicated as an adjunct to diet and other low-density lipoprotein-cholesterol (LDL-C) lowering therapies for the treatment of adult and adolescent patients aged 12 years and older with homozygous familial hypercholesterolaemia (HoFH).</p> </div>
Therapeutic Area (MeSH)
ATC Code
C10AX
ATC Item
N/A
Pharmacotherapeutic Group
Lipid modifying agents
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| Evinacumab | N/A | Evinacumab |
EMA Name
Evkeeza
Medicine Name
Evkeeza
Aliases
N/ANo risk management plan link.
